0

Journal Articles

in Prostate Cancer
 21-40 of 100 Articles
Original Contribution |  December 01, 2010 FREE
Active Surveillance Compared With Initial Treatment for Men With Low-Risk Prostate Cancer:  A Decision Analysis
Julia H. Hayes, MD; Daniel A. Ollendorf, MPH, ARM; Steven D. Pearson, MD, MSc, FRCP; et al.
JAMA. 2010;304(21):2373-2380. doi:10.1001/jama.2010.1720.
INCLUDES: , Supplemental Content
Capitol Health Call |  October 13, 2010
Coverage Being Questioned?
Mike Mitka
JAMA. 2010;304(14):1546. doi:10.1001/jama.2010.1417.
Capitol Health Call |  April 14, 2010
PSA Screening Debated
Mike Mitka
JAMA. 2010;303(14):1358. doi:10.1001/jama.2010.371.
Lab Reports |  April 07, 2010
Metastatic Prostate Cancer
Tracy Hampton, PhD
JAMA. 2010;303(13):1245. doi:10.1001/jama.2010.351.
Original Contribution |  March 17, 2010 FREE
Patient-Reported Long-term Outcomes After Conventional and High-Dose Combined Proton and Photon Radiation for Early Prostate Cancer
James A. Talcott, MD, SM; Carl Rossi, MD; William U. Shipley, MD; et al.
JAMA. 2010;303(11):1046-1053. doi:10.1001/jama.2010.287.
Special Communication |  October 21, 2009
Rethinking Screening for Breast Cancer and Prostate Cancer
Laura Esserman, MD, MBA; Yiwey Shieh, AB; Ian Thompson, MD
JAMA. 2009;302(15):1685-1692. doi:10.1001/jama.2009.1498.
INCLUDES: CME
Original Contribution |  September 16, 2009 FREE
Outcomes of Localized Prostate Cancer Following Conservative Management
Grace L. Lu-Yao, MPH, PhD; Peter C. Albertsen, MD; Dirk F. Moore, PhD; et al.
JAMA. 2009;302(11):1202-1209. doi:10.1001/jama.2009.1348.
INCLUDES: CME
Clinical Crossroads Update |  September 09, 2009
A 72-Year-Old Man With Localized Prostate Cancer—14 Years Later
Tom Delbanco, MD; Peter C. Albertsen, MD
JAMA. 2009;302(10):1105-1106. doi:10.1001/jama.2009.1281.
Original Contribution |  August 26, 2009 FREE
Hormonal Therapy Use for Prostate Cancer and Mortality in Men With Coronary Artery Disease–Induced Congestive Heart Failure or Myocardial Infarction
Akash Nanda, MD, PhD; Ming-Hui Chen, PhD; Michelle H. Braccioforte, BS; et al.
JAMA. 2009;302(8):866-873. doi:10.1001/jama.2009.1137.
Medical News & Perspectives |  June 24, 2009
Urology Group: Prostate Screening Should Be Offered Beginning at Age 40
Mike Mitka
JAMA. 2009;301(24):2538-2539. doi:10.1001/jama.2009.868.
Clinical Crossroads |  May 27, 2009
A 64-Year-Old Man With Low-Risk Prostate Cancer:  Review of Prostate Cancer Treatment
Martin G. Sanda, MD; Irving D. Kaplan, MD
JAMA. 2009;301(20):2141-2151. doi:10.1001/jama.2009.674.
INCLUDES: CME
Medical News & Perspectives |  May 06, 2009
Guideline Supports Long-term Use of Medication to Lower Prostate Cancer Risk
Mike Mitka
JAMA. 2009;301(17):1753-1754. doi:10.1001/jama.2009.560.
Medical News & Perspectives |  March 11, 2009
Promising Marker Found for Deadly Prostate Cancer
Bridget M. Kuehn
JAMA. 2009;301(10):1008. doi:10.1001/jama.2009.299.
Original Contribution |  January 07, 2009 FREE
Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other Cancers:  The Selenium and Vitamin E Cancer Prevention Trial (SELECT)
Scott M. Lippman, MD; Eric A. Klein, MD; Phyllis J. Goodman, MS; et al.
JAMA. 2009;301(1):39-51. doi:10.1001/jama.2008.864.
Health Agencies Update |  September 24, 2008
Prostate Cancer Screening
Bridget M. Kuehn
JAMA. 2008;300(12):1403. doi:10.1001/jama.300.12.1403-d.
Original Contribution |  July 09, 2008 FREE
Survival Following Primary Androgen Deprivation Therapy Among Men With Localized Prostate Cancer
Grace L. Lu-Yao, MPH, PhD; Peter C. Albertsen, MD; Dirk F. Moore, PhD; et al.
JAMA. 2008;300(2):173-181. doi:10.1001/jama.300.2.173.
JAMA Patient Page |  July 09, 2008 FREE
Prostate Cancer
John L. Zeller, MD, PhD; Cassio Lynm, MA; Richard M. Glass, MD
JAMA. 2008;300(2):236. doi:10.1001/jama.300.2.236.
INCLUDES: , Supplemental Content
Preliminary Communication |  June 18, 2008 FREE
Prostate Cancer–Specific Survival Following Salvage Radiotherapy vs Observation in Men With Biochemical Recurrence After Radical Prostatectomy
Bruce J. Trock, PhD; Misop Han, MD; Stephen J. Freedland, MD; et al.
JAMA. 2008;299(23):2760-2769. doi:10.1001/jama.299.23.2760.
The World in Medicine |  March 19, 2008
Prostate Cancer Genes
Joan Stephenson, PhD
JAMA. 2008;299(11):1252. doi:10.1001/jama.299.11.1252-b.
Original Contribution |  January 23, 2008 FREE
Androgen Suppression and Radiation vs Radiation Alone for Prostate Cancer:  A Randomized Trial
Anthony V. D’Amico, MD, PhD; Ming-Hui Chen, PhD; Andrew A. Renshaw, MD; et al.
JAMA. 2008;299(3):289-295. doi:10.1001/jama.299.3.289.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Original Investigation  |  Mar 11, 2013
Comparing 3 Techniques for Eliciting Patient Values for Decision Making About Prostate-Specific Antigen Screening:  A Randomized Controlled Trial
Michael Patrick Pignone, MD, MPH; Kirsten Howard, PhD, MPH; Alison Tytell Brenner, MPH; et al.
JAMA Internal Medicine
Editor's Correspondence  |  Mar 11, 2013
Prostate-Specific Antigen for Prostate Cancer Screening: A Different Strategy Should Be Planned
Giuseppe Lippi, MD; Camilla Mattiuzzi, MD; Gianfranco Cervellin, MD
JAMA Internal Medicine
Editor's Correspondence  |  Mar 11, 2013
Prostate Cancer Screening and Incidence: A Question of Causality
Jesse David Sammon, DO; Shyam Sukumar, MD; Quoc-Dien Trinh, MD, FRCSC
JAMA Internal Medicine
Editor's Correspondence  |  Mar 11, 2013
Prostate Cancer Screening and Incidence: A Question of Causality—Reply
David H. Howard, PhD
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems